Navigation Links
New England Biolabs Launches NEBNext(TM) DNA Sample Prep Master Mix Set 3 for Use with SOLiD(TM) 3
Date:2/23/2010

IPSWICH, Mass., Feb. 23 /PRNewswire/ -- New England Biolabs has expanded its line of reagents for sample preparation to include NEBNext™ DNA Sample Prep Master Mix Set 3, which has been validated for use with the SOLiD™ 3 System from Life Technologies. NEBNext reagents are a series of highly pure reagents that facilitate sample preparation for downstream applications, such as next generation sequencing. All reagents undergo stringent quality controls and functional validation, ensuring maximum yield, convenience and value.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090921/NE79207LOGO-b )

Available as sets, master mixes or modules, NEBNext reagents offer convenience and allow customization based on the sequencing platform being used. Reagents are available for each step of the library construction workflow, including end-repair, dA-tailing, adapter ligation and amplification. Additionally, NEB offers NEBNext™ dsDNA Fragmentase™, an enzyme-based solution for fragmentation of DNA.

For more information, visit www.NEBNext.com.

SOLiD is a trademark of Life Technologies.

SOURCE New England Biolabs

Back to top

RELATED LINKS
http://www.NEBNext.com

'/>"/>

SOURCE New England Biolabs
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Wellcome Trust Sanger Institute to use NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for Next Generation Sequencing
2. Organogenesis CEO Geoff MacKay and COO / CFO Gary Gillheeney Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winners in New England
3. Ontario Institute for Cancer Research Validates NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for use in Next Generation Sequencing
4. First U.K. Stem Cell Awareness Rally to Take Place in Manchester, England on August 9th, 2009
5. Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax
6. New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery
7. Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine
8. New England Peptide Forms Scientific Advisory Board
9. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.
10. New England Peptide Names Director of Chemical Development
11. New England Peptide Implements Quality Management System, Prepares for ISO 9001: 2008 Registration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Microbial genomics ... Awards. uBiome is one of just six company finalists in the Health & ... to uBiome, companies nominated as finalists in this year’s awards include Google, SpaceX, ...
(Date:12/8/2016)... -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), ... products to treat rare diseases where there is an ... hosting an Investor Webcast Event Friday, December 16, 2016, ... defense regulators (IDRs) as a new drug class, as ... recently announced and published Phase 2 clinical data for ...
(Date:12/8/2016)... Eutilex Co. Ltd. today announced that it ... A financing. This financing round included participation from DS ... Bio Angel. This new funding brings the total capital ... since its founding in 2015. The ... commercialization of its immuno-oncology programs, expand its R&D capabilities ...
(Date:12/7/2016)... ... 07, 2016 , ... ACEA Biosciences, Inc. presented today updated ... trial for its lead drug candidate, AC0010, at the World Conference on Lung ... determine the safety, antitumor activity, and recommended phase II dosage of AC0010 in ...
Breaking Biology Technology:
(Date:11/29/2016)... , November 29, 2016 Nearly one billion matches ... Reading ... DERMALOG ... of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's ...
(Date:11/22/2016)... According to the new market research report "Biometric System Market ... Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, and Region ... to grow from USD 10.74 Billion in 2015 to reach USD 32.73 ... Continue Reading ... ...
(Date:11/19/2016)... -- Securus Technologies, a leading provider of civil and ... and monitoring, announced today that it has offered a ... independent technology judge determine who has the largest and ... calling platform, and the best customer service. ... what we do – which clearly is not the ...
Breaking Biology News(10 mins):